• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

一名患有机化性肺炎并伴有非典型慢性髓性白血病的患者在接受类固醇治疗期间发生肺泡蛋白沉积症。

Pulmonary alveolar proteinosis developing during steroid treatment in a patient with organizing pneumonia in association with atypical chronic myeloid leukemia.

作者信息

Hosoda Chiaki, Saito Keisuke, Fujimoto Shota, Yamanaka Yumie, Watanabe Naoaki, Miyagawa Hanae, Kurita Yusuke, Seki Yoshitaka, Kinoshita Akira, Endo Yasuhiko, Kuwano Kazuyoshi

机构信息

Department of Internal Medicine, Division of Respiratory Medicine The Jikei University Daisan Hospital Tokyo Japan.

Department of Pathology The Jikei University School of Medicine Tokyo Japan.

出版信息

Clin Case Rep. 2019 Jan 31;7(3):477-481. doi: 10.1002/ccr3.2014. eCollection 2019 Mar.

DOI:10.1002/ccr3.2014
PMID:30899476
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6406221/
Abstract

Organizing pneumonia (OP) and pulmonary alveolar proteinosis (PAP) are rare complications in patients with hematologic disorders. We herein report a case of PAP that developed during steroid treatment for OP in a patient with atypical chronic myeloid leukemia. Physicians should pay close attention to these complications in patients with hematologic malignancies.

摘要

机化性肺炎（OP）和肺泡蛋白沉积症（PAP）是血液系统疾病患者中罕见的并发症。我们在此报告1例非典型慢性髓性白血病患者在接受OP类固醇治疗期间发生PAP的病例。医生应密切关注血液系统恶性肿瘤患者的这些并发症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f34/6406221/c193eff89fdc/CCR3-7-477-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f34/6406221/b9dc71f2268c/CCR3-7-477-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f34/6406221/245d2d656dc6/CCR3-7-477-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f34/6406221/c193eff89fdc/CCR3-7-477-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f34/6406221/b9dc71f2268c/CCR3-7-477-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f34/6406221/245d2d656dc6/CCR3-7-477-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f34/6406221/c193eff89fdc/CCR3-7-477-g003.jpg

相似文献

1
Pulmonary alveolar proteinosis developing during steroid treatment in a patient with organizing pneumonia in association with atypical chronic myeloid leukemia.一名患有机化性肺炎并伴有非典型慢性髓性白血病的患者在接受类固醇治疗期间发生肺泡蛋白沉积症。
Clin Case Rep. 2019 Jan 31;7(3):477-481. doi: 10.1002/ccr3.2014. eCollection 2019 Mar.
2
Secondary pulmonary alveolar proteinosis in hematologic malignancies.血液系统恶性肿瘤中的继发性肺泡蛋白沉积症
Hematol Oncol Stem Cell Ther. 2014 Dec;7(4):127-35. doi: 10.1016/j.hemonc.2014.09.003. Epub 2014 Oct 6.
3
Secondary pulmonary alveolar proteinosis in a patient with chronic myeloid leukemia in the accelerated phase.一名处于加速期的慢性髓性白血病患者发生的继发性肺泡蛋白沉积症。
Tokai J Exp Clin Med. 2008 Dec 20;33(4):146-9.
4
Pulmonary alveolar proteinosis complicating chronic myelogenous leukemia.
Cancer. 1980 Oct 15;46(8):1763-6. doi: 10.1002/1097-0142(19801015)46:8<1763::aid-cncr2820460811>3.0.co;2-k.
5
Successful whole lung lavage in a child with pulmonary alveolar proteinosis secondary to hematologic malignancy.成功对继发于血液系统恶性肿瘤的肺泡蛋白沉积症患儿进行全肺灌洗。
Pediatr Pulmonol. 2022 Jan;57(1):308-310. doi: 10.1002/ppul.25718. Epub 2021 Oct 13.
6
Autoimmune pulmonary alveolar proteinosis exacerbated by steroid therapy due to misdiagnosis as anti-aminoacyl-tRNA synthetase (ARS) antibody positive- interstitial pneumonia: a case report.自身免疫性肺性肺泡蛋白沉积症误诊为抗氨酰基-tRNA 合成酶（ARS）抗体阳性间质性肺炎，经激素治疗加重：病例报告。
BMC Pulm Med. 2022 Mar 31;22(1):120. doi: 10.1186/s12890-022-01909-z.
7
Pulmonary alveolar proteinosis: a complication in patients with hematologic malignancy.
Neth J Med. 2000 May;56(5):193-7. doi: 10.1016/s0300-2977(00)00025-5.
8
Intestinal Behçet's disease complicated by myelodysplastic syndrome and secondary pulmonary alveolar proteinosis: a case report.肠型贝赫切特病并发骨髓增生异常综合征和继发性肺泡蛋白沉积症：病例报告。
BMC Gastroenterol. 2021 Dec 20;21(1):488. doi: 10.1186/s12876-021-02065-0.
9
Pulmonary alveolar proteinosis: time to shift?肺泡蛋白沉积症：是时候做出改变了吗？
Expert Rev Respir Med. 2015 Jun;9(3):337-49. doi: 10.1586/17476348.2015.1035259. Epub 2015 Apr 12.
10
Unsuspected pulmonary alveolar proteinosis complicating acute myelogenous leukemia.
Chest. 1976 Mar;69(3):433-5. doi: 10.1378/chest.69.3.433.

引用本文的文献

1
Pulmonary Alveolar Proteinosis During Intensive Immunosuppressive Treatment for Acute Exacerbation of Interstitial Pneumonia: A Case Report and Literature Review.间质性肺炎急性加重期强化免疫抑制治疗期间发生的肺泡蛋白沉积症：一例报告及文献复习
Cureus. 2024 Nov 28;16(11):e74669. doi: 10.7759/cureus.74669. eCollection 2024 Nov.
2
Pathogenesis-driven treatment of primary pulmonary alveolar proteinosis.以发病机制为导向的原发性肺泡蛋白沉积症治疗。
Eur Respir Rev. 2024 Aug 14;33(173). doi: 10.1183/16000617.0064-2024. Print 2024 Jul.
3
A Comprehensive Outlook on Pulmonary Alveolar Proteinosis-A Review.

本文引用的文献

1
GM-CSF Autoantibody-positive Pulmonary Alveolar Proteinosis with Simultaneous Myeloproliferative Neoplasm.伴有同时性骨髓增殖性肿瘤的GM-CSF自身抗体阳性肺泡蛋白沉积症
Intern Med. 2017;56(4):435-439. doi: 10.2169/internalmedicine.56.6920. Epub 2017 Feb 15.
2
Management of pulmonary alveolar proteinosis with whole lung lavage using extracorporeal membrane oxygenation support in a postrenal transplant patient with graft failure.在一名肾移植术后移植物功能衰竭患者中，使用体外膜肺氧合支持进行全肺灌洗治疗肺泡蛋白沉积症
Ann Card Anaesth. 2016 Apr-Jun;19(2):379-82. doi: 10.4103/0971-9784.179627.
3
Possible Involvement of Lung Cells Harboring an Abnormal Karyotype in the Pathogenesis of Pulmonary Alveolar Proteinosis Associated with Myelodysplastic Syndrome.
肺肺泡蛋白沉积症的全面概述-综述。
Int J Mol Sci. 2024 Jun 28;25(13):7092. doi: 10.3390/ijms25137092.
4
COVID-19 and severe pulmonary alveolar proteinosis (PAP): A case report.新型冠状病毒肺炎与重症肺泡蛋白沉积症：一例报告
Heliyon. 2023 Jul 7;9(7):e18099. doi: 10.1016/j.heliyon.2023.e18099. eCollection 2023 Jul.
5
A case of development of autoimmune pulmonary alveolar proteinosis during the treatment of hypersensitivity pneumonitis.1例过敏性肺炎治疗期间发生自身免疫性肺泡蛋白沉积症的病例。
Respir Med Case Rep. 2023 May 16;44:101862. doi: 10.1016/j.rmcr.2023.101862. eCollection 2023.
6
Beyond "Big Eaters": The Versatile Role of Alveolar Macrophages in Health and Disease.超越“大食者”：肺泡巨噬细胞在健康和疾病中的多功能角色。
Int J Mol Sci. 2021 Mar 24;22(7):3308. doi: 10.3390/ijms22073308.
具有异常核型的肺细胞可能参与与骨髓增生异常综合征相关的肺泡蛋白沉积症的发病机制。
Ann Am Thorac Soc. 2015 Aug;12(8):1251-3. doi: 10.1513/AnnalsATS.201503-175LE.
4
Secondary pulmonary alveolar proteinosis complicating myelodysplastic syndrome results in worsening of prognosis: a retrospective cohort study in Japan.继发于骨髓增生异常综合征的肺朗格汉斯细胞组织细胞增生症导致预后恶化：日本的一项回顾性队列研究。
BMC Pulm Med. 2014 Mar 5;14:37. doi: 10.1186/1471-2466-14-37.
5
GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.GATA2 缺陷：一种造血、淋巴和免疫功能多样的疾病。
Blood. 2014 Feb 6;123(6):809-21. doi: 10.1182/blood-2013-07-515528. Epub 2013 Nov 13.
6
Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan.继发性肺泡蛋白沉积症的临床特征：日本的生前病例
Eur Respir J. 2011 Feb;37(2):465-8. doi: 10.1183/09031936.00092910.
7
Comparative study of high-resolution CT findings between autoimmune and secondary pulmonary alveolar proteinosis.自身免疫性与继发性肺泡蛋白沉积症高分辨率 CT 表现的对比研究。
Chest. 2009 Nov;136(5):1348-1355. doi: 10.1378/chest.09-0097.
8
Secondary pulmonary alveolar proteinosis: a confusing and potentially serious complication of hematologic malignancy.继发性肺泡蛋白沉积症：血液系统恶性肿瘤中一种令人困惑且可能严重的并发症。
J Thorac Imaging. 2009 May;24(2):115-8. doi: 10.1097/RTI.0b013e3181930ed6.
9
Organizing pneumonia in patients with hematologic malignancies: a steroid-responsive lesion.血液系统恶性肿瘤患者的机化性肺炎：一种对类固醇有反应的病变。
Respir Med. 2007 Jan;101(1):162-8. doi: 10.1016/j.rmed.2006.03.035. Epub 2006 May 15.
10
Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis.肺泡蛋白沉积症患者全肺灌洗后的长期持久获益
Eur Respir J. 2004 Apr;23(4):526-31. doi: 10.1183/09031936.04.00102704.